61. Inside The New Long COVID GLP-1 Study

About this episode

Dr. Khan interviews Dr. Julia Moore-Vogel about a new study using tirzepatide to treat Long COVID.

Dr Khan interviews Dr. Julia Moore-Vogel, Scripps Researcher and lead scientist of the new study using tirzepatide to treat Long COVID. The study is called LoCITT-T, and it is actively enrolling participants. They discuss the study's design, eligibility criteria, and the potential benefits of the drug. Julia shares her personal experience with long COVID and how it has influenced her work. The conversation also covers the importance of making clinical trials accessible to those with disabilit...

People in this episode

Host: Dr. Zeest Khan

Guest: Dr. Julia Moore-Vogel

Topics covered

• Long COVID
• clinical trials
• health research
• treatment options
• disability access

Keywords

• Long COVID
• tirzepatide
• clinical trials
• health research
• disability

Mentioned in this episode

Organizations: Scripps Research

Products: tirzepatide

Books & works: LoCITT-T

More episodes of Long Covid, MD

• 71. Is My Diet Causing My Symptoms? How to Identify Food Triggers Without Harming Your Health · May 19, 2026 · 22 min
• 70. Using AI for Your Medical Care · May 5, 2026 · 44 min
• BONUS: Why Patients Have to Perform for their Doctors (Medical Culture Explained) · April 29, 2026 · 13 min
• 69. Protecting Our Caregivers · March 24, 2026 · 20 min
• 68. The NEW Study on Stellate Ganglion Block · February 28, 2026 · 8 min
• 67. Stellate Ganglion Blocks, Explained by Experts · February 28, 2026 · 45 min